Crystallization improvements of a diastereomeric kinetic resolution through understanding of secondary nucleation

Organic Process Research and Development

Volumn 12, Issue 2, 2008, Pages 243-248

  Mousaw, Patrick ^a   Saranteas, Kostas ^a   Prytko, Bob ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 58149156104     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op700276w     Document Type: Article

References (15)

1. FDA'S Policy Statement for the Development of New Stereoisomeric Drugs. http://www.fda.gOv/cder/guidance/stereo.htm5/1 /1992.
2. Mersmann, A. Crystallization Technology Handbook; Marcel Dekker, Inc: New York, 1995; pp 417-418..
3. Barrett, P.; Glennon, B. Part. Part. Syst. Charact. 1999, 16, 207.
4. Worlitschek, J.; Mazzotti, M. Part. Part. Syst. Charact. 2003, 20, 12-17.
5. Tavare, N. Industrial Crystallization: Process Simulation Analysis and Design; Plenum Press: New York 1995; pp 64-65..
6. Jones, A. G. Crystallization Process Systems: Butterworth- Heinemann: Oxford, 2002; p 150.
7. Genck, W. Crystallization - Part 1. Chem. Process. 2003, (October), 63.
8. Wakao, H.; Hiraguchi, H.; Ishii, T. Chem. Eng. J. 1987, 35, 169.
9. Daudey. P. J.: Van Rosmalen, G. M.: De Jong, E. J. J. Cryst. Growth. 1990, 99, 1076.
10. Togkalidou. T.; Tung, H.-H.; Sun, Y.; Andrews, A. T.; Braatz, R. D. Ind. Eng. Chem. Res. 2004, 43, 6168.
11. Oullion, M.; Puel, F.; Fevotte, G.; Righini, S.; Carvin, P. Chem. Eng. Sci. 2007, 62, 833.
12. Genck, W. Scale Up, Simulation and New Technologies - Part 2. Chem. Process. 2003, (December), 37.
13. VisiMix Turbulent, VisiMix Ltd., Jerusalem, Israel, 2000. http://www.visimix.com.
14. Qian, R. Y.; Botsaris, G. D. Chem. Eng. Sci. 1997, 52, 3429.
15. Qian, R. Y.; Botsaris, G. D. Chem. Eng. Sci. 1998, 53, 1745.